ARCHIVES

Long-Term Effect Of One Phase III Trial: Benefit For Thousands Of Patients

This article is from The Cancer Letter archive.

Vol. 32 No. 11 | November 27, 2009

Download PDF Visit The Full Archive

Related Articles

Enzalutamide Reduced Risk of Progression By 81 Percent in Metastatic Prostate Cancer

June 27, 2014

It is The First FDA Withdrawl Of An Accelerated Approval

November 18, 2011

FDA Advisors: DepoCyt May Test Accelerated Approval Mechanism

November 27, 1998

In Brief: LSU Will Be Headquarters For National Pancreatic Project; Budget For First Year Will Be $1 Million

December 6, 1974

GSK Vaccine Prevents Lesions Associated With HPV

July 28, 2006

Zvi Fuks of Memorial Sloan-Kettering arrested and charged with securities fraud related to sale of ImClone stock.

March 11, 2005